UNITED BIOMEDICAL INC ASA

Nature of Business: Manufacturer (Biotechnology/Pharmaceutical Factory)

Company Overview:

United Biomedical, Inc. (UBI) Asia is a prominent biotechnology company based in Taiwan, specializing in the research, development, and manufacturing of synthetic peptide-based vaccines and diagnostics. The company operates high-tech production facilities that adhere to international quality standards, including cGMP (current Good Manufacturing Practice) certifications. UBI Asia focuses on innovative immunotherapy and vaccine technologies for both human and animal health, managing its own R&D laboratories and large-scale manufacturing plants. They are primarily recognized as a manufacturer rather than a trading company, as they possess the infrastructure to develop and produce proprietary biopharmaceutical products.

United Biomedical Inc. Asia (UBI Asia) specializes in the research, development, and manufacturing of immunotherapeutic and diagnostic products. Its primary offerings include:

Diagnostic Products:

1. UBI HIV-1/2 EIA: An enzyme immunoassay for the detection of antibodies to HIV-1 and HIV-2.

2. UBI HCV EIA: An enzyme immunoassay for the detection of antibodies to the Hepatitis C virus.

3. UBI HTLV I/II EIA: An enzyme immunoassay for the detection of antibodies to Human T-cell Lymphotropic Virus types I and II.

4. Rapid Diagnostic Tests: Various rapid test kits for infectious diseases.

Therapeutic and Vaccine Products:

1. Synthetic Peptide Vaccines: Development of proprietary peptide-based vaccines targeting chronic diseases and viral infections.

2. Immunotherapeutics: Research and development of therapeutic vaccines for conditions such as Alzheimer's disease, hypercholesterolemia, and other chronic illnesses.

3. Monoclonal Antibodies: Development of therapeutic antibodies for targeted medical treatments.

Contract Manufacturing Services:

1. Peptide Synthesis: Custom synthesis of high-quality peptides for pharmaceutical and research applications.

2. Biologics Manufacturing: Contract development and manufacturing organization (CDMO) services for vaccines and protein-based therapeutics.